Author

Abdur Rehman

The University of Texas MD Anderson Cancer CenterORCID 0000-0003-3785-2007Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Abdur Rehman1 paper · Hazara University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Assay:metabolomics· 1

Frequent Co-Authors

Fuliang ChuiD· 2 shared JingJing CaoiD· 2 shared Jingwei LiuiD· 2 shared Jinsheng WengiD· 2 shared Matthew D. RichardiD· 2 shared Sattva Swarup NeelapuiD· 2 shared Sridevi Patchva· 2 shared Abhinav K. JainiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Fuliang ChuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A novel KIR3DL2-directed CAR T-cell therapy for cutaneous and systemic T-cell lymphomas

Federico Mario Aletti, Jinsheng Weng, Cao Cuong Le, Jingwei Liu, Faezeh Darbaniyan, Abdur Rehman, Matthew D. Richard, Selin Kolsuz, Xiaoyun Cheng, Sridevi Patchva, Yongfu Tang, Chun-Yen Lin, JingJing Cao, Kamini Singh, Shriya D. Reddy, , Sattva S. Neelapu

This paper develops a KIR3DL2-directed CAR T-cell therapy for T-cell lymphomas, showing preclinical efficacy and safety in xenograft models.

bioRxiv · Nov 6, 2026 · PreprintImmunology

Microbial valerate is associated with CAR T dysbiosis and its supplementation enhances CAR T function in B-cell lymphoma

Lubna Rehman, Wenting Song, Abdur Rehman, Kamini Singh, Shiv Govind Rawat, Faezeh Darbaniyan, Cao Cuong Le, Federico Mario Aletti, Jinsheng Weng, Jingwei Liu, Xiayoun Cheng, Yongfu Tang, Sridevi Patchva, Matthew D. Richard, Fuliang Chu, , Neeraj Y. Saini

This study links low stool valerate to CAR T-cell dysfunction in B-cell lymphoma and shows valerate supplementation improves CAR T function.

bioRxiv · Sep 3, 2026 · PreprintCancer Biology